Description
Cures 2.0 is the follow up legislation to the landmark, bipartisan 21st Century Cures Act of 2016, that led to the streamlining and improvements in medical care, research, drug development and more.
Learn more about the features of the Cures 2.0 bill and how it seeks to make new treatments more accessible to patients. Cures 2.0 endeavors to take advantage of new technologies and modernization efforts to improve approval and regulatory processes, bring more patient empowerment and engagement in drug development and clinical trials, build on infrastructure goals to expand telehealth, and improve public health and preparedness. An impassioned perspective from a patient will encapsulate the imperative for timely legislative enactment of Cures 2.0.
Speakers:
- Diana DeGette, U.S. Representative, Colorado
- Max Schill, Patient and Patient Advocate, New Jersey
- Fred Upton, U.S. Representative, Michigan
